Asthma Management Issues in Infancy and Childhood

Global Initiative for Asthma (GINA): pocket guide for asthma management and prevention — updated 2004 [online]. Available from URL: http://www.ginasthma.org [Accessed 2005 Jan 17] National Asthma Education and Prevention Program (NAEPP) Expert Panel Report-2: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Heart, Lung, and Blood Institute, NIH, US Department of Health And Human Services, 1997: 1–147. NIH Publication No. 97-4051 Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541–5 Stein RT, Holberg CJ, Morgan WJ, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997; 52: 946–52 Weiss ST, Van Natta ML, Zeiger RS. Relationship between increased airway responsiveness and asthma severity in the Childhood Asthma Management Program. Am J Respir Crit Care Med 2000; 162: 50–6 Nelson HS, Szefler SJ, Jacobs J, et al. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999; 104: 775–85 Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95: 500–5 Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: the International Study of Asthma and Allergies in Childhood (ISAAC) steering committee. Lancet 1998; 351: 1225–32 Yang KD. Aspects of global environment, genetics and management. Chang Gung Med J 2000; 23: 641–61 Hsieh KH, Shen JJ. Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988; 25: 73–82 Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268–72 Ingram JM, Sporik R, Rose G, et al. Quantitative assessment of exposure to dog (Can f1) and cat (Fel d1) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol 1995; 96: 449–56 Chan-Yeung M, Becker A, Lam J, et al. House dust mite allergen levels in two cities in Canada: effects of season, humidity, city and home characteristics. Clin Exp Allergy 1995; 25: 240–6 Beaumont F, Kauffman HE, Sluiter HJ, et al. A volumetric-aerobiologic study of seasonal fungus prevalence inside and outside dwellings of asthmatic patients living in northeast Netherlands. Ann Allergy 1984; 53: 486–92 Ezeamuzie CI, Al-Ali S, Khan M, et al. IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000; 121: 300–7 Celenza A, Fothergill J, Kupek E, et al. Thunderstorm associated asthma: a detailed analysis of environmental factors. BMJ 1996; 312(7031): 604–7 Lubs MLE. Empiric risks for genetic counseling in families with allergy. J Pediatr 1972; 80: 26–31 Ownby DR. Environmental factors versus genetic determinants of childhood inhalant allergies. J Allergy Clin Immunol 1990; 86: 279–87 Cookson WO, Moffatt MF. Genetics of asthma and allergic disease. Hum Mol Gene 2000; 9: 2359–64 Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001; 163: 965–9 D’amato M, Vitiani LR, Petrelli G, et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes: a population study. Am J Respir Crit Care Med 1998; 158: 1968–73 Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426–30 Panhuysen CIM, Bleecker ER, Koeter GH, et al. Dutch approach to the genetics of asthma. Clin Exp Allergy 1995; 25Suppl. 2: 35–8 Sears MR, Herbison GP, Holdaway MD, et al. The relative risks of sensitivity to grass pollen, house dust mite, and cat dander in the development of childhood asthma. Clin Exp Allergy 1989; 19: 419–24 Sears MR, Burrfows B, Flannery EM, et al. Atopy in childhood. I: gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy 1993; 23: 826–31 Jaakkola JJ, Nafstad P, Magnus P. Environmental tobacco smoke, parental atopy, and childhood. Environ Health Perspect 2001; 109: 579–82 Ronchetti R, Bonci E, Cutera R, et al. Enhanced allergic sensitization related to parental smoking. Arch Dis Child 1992; 67: 496–500 Ronchetti R, Macri F, Ciofetta G, et al. Increased serum immunoglobulin E and increased prevalence of eosinophilia in nine year old children of smoking parents. J Allergy Clin Immunol 1990; 86: 400–7 Barrios C, Brawand P, Berney M, et al. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996; 26: 1489–96 Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9 to 11 year old children. BMJ 1995; 310: 1225–9 Horwitz RJ, Busse WW. Inflammation and asthma. Clin Chest Med 1995; 16: 583–602 Roche WR. Fibroblasts and asthma. Clin Exp Allergy 1991; 21: 545–8 Hart PH. Regulation of the inflammatory response in asthma by mast cell products. Immunol Cell Biol 2001; 79: 149–53 Kam KL, Hsieh KH. Comparison of three in vitro assays for serum IgE with skin testing in asthmatic children. Ann Allergy 1994; 73: 329–36 Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271–7 Huss K, Adkinson NF, Eggleston PA, et al. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol 2001; 107: 48–54 Sly PD. Peak expiratory flow monitoring in pediatric asthma: is there a role? J Asthma 1996; 33: 277–87 Ting S. Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines. Ann Allergy Asthma Immunol 2002; 88: 326–30 Modl M, Eber E, Steinbrugger B, et al. Comparing methods for assessing bronchial responsiveness in children: single step cold air challenge, multiple step cold air challenge, and histamine provocation. Eur Respir J 1995; 8: 1742–7 Hopp RJ, Bewtra AK, Nair NM, et al. Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984; 74: 154–8 Warner JA, Jones AC, Miles EA, et al. Materofetal interaction and allergy. Allergy 1996; 51: 447–51 Johnson CC, Ownby DR, Peterson EL. Parental history of atopic disease and concentration of cord blood IgE. Clin Exp Allergy 1996; 26: 624–9 Tariq SM. Allergen avoidance in the primary prevention of atopy. Br J Clin Pract 1996; 50: 99–102 Liu CA, Wang CL, Chuang H, et al. Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J Allergy Clin Immunol 2003: 112: 899–904 Bjerke T, Hedegaard M, Henriksen TB, et al. Several genetic and environmental factors influence cord blood IgE concentration. Pediatr Allergy Immunol 1994; 5: 88–94 Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076–9 Gehring U, Bolte G, Borte M, et al. Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. LISA study group: Lifestyle-Related Factors on the Immune System and the Development of Allergies in Childhood. J Allergy Clin Immunol 2001; 108: 847–54 McKeever TM, Lewis SA, Smith C, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002; 109: 43–50 Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996; 347: 1792–6 Shearer GM, Chougnet C, Shearer MS. Atopic disease and immunologic response. Science 1997; 276: 17–8 Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 1999; 103: 376–87 Long-term effects of budesonide or nedocromil in children with asthma: the Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343: 1054–63 Bisgaard H. Use of inhaled corticosteroids in pediatric asthma. Pediatr Pulmonol 1997; 15: 27S–33S Bustos GJ, Bustos D, Bustos GJ, et al. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995; 25: 568–73 Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001; 108: E48 Bibi H, Khvolis E, Shoseyov D, et al. The prevalence of gastroesophageal reflux in children with tracheomalacia and laryngomalacia. Chest 2001; 119(2): 409–13 Avital A, Uwyyed K, Berkman N, et al. Exhaled nitric oxide and asthma in young children. Pediatr Pulmonol 2001; 32: 308–13 Klinnert MD, Nelson HS, Price MR, et al. Onset and persistence of childhood asthma: predictors from infancy. Pediatrics 2001; 108: E69 Bisgaard H, Munck SL, Nielsen JP, et al. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336: 649–51 Berger I, Argaman Z, Schwartz SB, et al. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol 1998; 26: 162–6 Springer C, Bar-Yishay E, Uwayyed K, et al. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990; 9: 181–5 Bisgaard H. Leukotriene modifiers in pediatric asthma management. Pediatrics 2001; 107: 381–90 Palmqvist M, Arvdsson P, Beckman O, et al. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14: 29–34 Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373–81 Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95: 29–33 Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90: 32–42 Barnes PJ. Inhaled glucocorticoid for asthma. N Engl J Med 1995; 332: 868–75 Welch MJ. Inhaled steroids and severe viral infections. J Asthma 1994; 31: 43–50 Newacheck PW, Halfon N. Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med 2000; 154: 287–93 Barnes PJ. Scientific rationale for inhaled combination theory with long-acting β-agonists and corticosteroids. Eur Respir J 2002; 19: 182–91 Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000; 106: E8 Doull IJM, Campbell MJ, Holgate ST. The growth suppressive effects of regular inhaled corticosteroids are relatively short term. Arch Dis Child 1998; 78: 172–3 Rubin BK, Albers GM. Use of anticholinergic bronchodilation in children. Am J Med 1996; 100: 49S–53S Kajosaari M, Syvanen P, Forars M, et al. Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol 2000; 11: 198–202 Tsai YG, Lee MY, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001; 139: 433–7 Safdar B, Cone DC, Pham KT. Subcutaneous epinephrine in the prehospital setting. Prehosp Emerg Care 2001; 5: 200–7 Malling HJ, Weeks B. EAACI Immunotherapy position paper. Allergy 1993; 48: 9–35 Adkinson NF, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for children in allergic asthma. N Engl J Med 1997; 336: 324–31 Dempsey OJ, Wilson AM, Sims EJ, et al. Additive bronchoprotective and bronchodilator defects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids. Chest 2000; 117: 950–3 Radielovic P, Morley J, Hansel TT, et al. Zaditen SRO permits once-daily dosing with superior efficacy in the prophylaxis of asthma. J Asthma 1995; 32: 105–15 International Consensus Report on diagnosis and management of asthma. Eur Respir J 1992; 5: 601–41 D’Ambrosio FP, Ricciardi L, Isola S, et al. Rush sublingual immunotherapy in Parietaria allergic patients. Allergol Immunopathol (Madr) 1996; 24: 146–51 Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 1999; 82: 485–90 Dry J. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95: 156–7 Medici TC, Schmid AZ, Hacki M. Are asthmatics salt-sensitive? A preliminary controlled study. Chest 1993; 104: 1138–43 Anah CO, Jarike L, Baig H. High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 1980; 32: 132–7 Collipp PJ, Goldzier S, Weiss N, et al. Pyridoxine treatment of childhood bronchial asthma. Ann Allergy 1975; 35: 93–7 Schwarz J. Caffeine intake and asthma symptoms. Ann Epidemiol 1992; 2: 627–35 Kong XT, Fang HT, Jiang GQ, et al. Treatment of acute bronchiolitis with Chinese herbs. Arch Dis Child 1993; 68: 468–71 Schachter EN, Doyle CA, Beck GJ. A prospective study of asthma in a rural community. Chest 1984; 85: 623–30 Schwartz J, Gold D, Dockery DW, et al. Predictors of asthma and persistent wheeze in a national sample of children in the United States. Am Rev Respir Dis 1990; 142: 555–62 Foucard T, Sjoberg O. A prospective 12-year follow-up study of children with wheezy bronchitis. Acta Paediatr Scand 1984; 73: 577–83 Larsson ML, Frisk M, Hallstrom J, et al. Environmental tobacco smoke exposure during childhood is associated with increased prevalence of asthma in adults. Chest 2001; 120: 711–7 Saga R, Mochizuki H, Tokuyama K, et al. Relationship between bronchial hyperresponsiveness and development of asthma in wheezy infants. Chest 2001; 119: 685–90 Hopes E, McDougall C, Christie G, et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ 1998; 316: 664 Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999; 22: 168–70 Rusnak JM, Kisabeth RM, Herbert DP, et al. Pharmacogenomics: a clinician’s primer on emerging technologies for improved patient care. Mayo Clinic Proc 2001; 76: 299–309